Sarah has 14 years of consulting experience for leading pharmaceutical and biotech companies. As a leader of the European value and access team, she specializes in international market access and pricing across a wide range of therapeutic areas.
Sarah’s areas of expertise center on strategic market access. Her special interests include evaluation of early stage products, pricing and reimbursement strategy, and innovative contracting.
Prior to focusing on value and access, Sarah spent time within ZS driving strategic marketing and go-to-market commercialization initiatives with a range of pharma and medtech clients across Europe, Latin America and Asia.
Sarah holds an MSc in health policy at Imperial College. She graduated with a master’s in biochemistry from the University of Oxford.